Mar 02, 2022

Active agent in Australian-developed nasal spray highly active against 'Omicron'

Active agent in Australian-developed nasal spray highly active against 'Omicron'

Australian biotechnology and life sciences media platform, BiotechDispatch, featured the news of Starpharma's latest announcement regarding SPL7013's virucidal activity against Omicron. Read the full article here

 This contains certain forward-looking statements.